Skip to main content
Journal of Biomedical Optics logoLink to Journal of Biomedical Optics
. 2014 Aug 21;19(8):086017. doi: 10.1117/1.JBO.19.8.086017

Microcirculatory changes identified by photoacoustic microscopy in patients with complex regional pain syndrome type I after stellate ganglion blocks

Yong Zhou a, Xiaobin Yi b,*, Wenxin Xing a, Song Hu a, Konstantin I Maslov a, Lihong V Wang a,*
PMCID: PMC4407664  PMID: 25144451

Abstract.

Complex regional pain syndrome (CRPS) is a chronic pain syndrome that causes intractable pain, disability, and poor quality of life for patients. The etiology and pathophysiology of CRPS are still poorly understood. Due to a lack of proper diagnostic tools, the prognosis of CRPS is primarily based on clinical observation. The objective of this work is to evaluate a new imaging modality, photoacoustic microscopy (PAM), for assisting diagnoses and monitoring the progress and treatment outcome of CRPS. Blood vasculature and oxygen saturation (sO2) were imaged by PAM from eight adult patients with CRPS-1. Patients’ hands and cuticles were imaged both before and after stellate ganglion block (SGB) for comparison. For all patients, both vascular structure and sO2 could be assessed by PAM. In addition, more vessels and stronger signals were observed after SGB. The results show that PAM can help diagnose and monitor CRPS.

Keywords: complex regional pain syndrome, photoacoustic microscopy, stellate ganglion block

1. Introduction

Complex regional pain syndrome (CRPS) is a pain disorder characterized by severe and disproportionate pain, autonomic changes such as abnormal regulation of blood flow and sweating, edema of skin and subcutaneous tissues, motor disorders, and dystrophic changes. The pathophysiological mechanism of CRPS is still poorly understood, although our knowledge of this syndrome has increased significantly.13 Multiple factors, including vascular and microcirculatory dysfunction, neurogenic inflammation,4 and alteration in sympathetic and catecholaminergic function, as well as peripheral and central sensitization may all play important roles in the pathogenesis of this disabling syndrome.5 However, due to the connection between the microvascular blood supply and the development of neuropathic pain,6 microcirculatory parameters including rate and volume of blood flow and tissue oxygen saturation (sO2) are of considerable interest for potentially diagnosing CRPS and monitoring its progress.

There is increasing evidence to show that inflammatory processes and immune reactions are involved in the pathophysiology of CRPS.7 In a systemic review and meta-analysis study, Parkitny et al.4 concluded that CRPS is associated with proinflammatory states in the blood, blister fluids, and cerebrospinal fluid. The CRPS-related inflammation may change the sympathetic tone of blood vessels and, therefore, affect blood supply and tissue oxygenation. The acute and chronic phases of CRPS demonstrate different inflammatory features in both clinical manifestations and inflammatory profiles. The measurement of microcirculatory parameters, such as blood flow rate, blood volume, and blood oxygen saturation (sO2), can be used to potentially diagnose the presence of CRPS, to indicate the activity of the disease, and to monitor the effectiveness of the therapeutic intervention.

In pain studies, traditional techniques for detecting microcirculatory parameters include functional magnetic resonance imaging (fMRI) and positron emission tomography (PET).8 However, both have limitations: fMRI makes indirect measurements by the blood-oxygenation-level dependent method9,10 or makes direct flow measurements with low sensitivity by the arterial spin labeling method;11 PET has to use radioactive tracers to measure blood flow directly.12 To overcome these limitations, optical methods provide alternative ways to make direct, sensitive, noninvasive, and nonionizing measurements of blood flow and sO2 in pain studies.1316 Optical spectroscopic methods, such as near-infrared spectroscopy13 and micro-lightguide spectrophotometry,14 can provide noninvasive measurement of average blood flow and sO2, but with poor spatial resolution. Optical coherence tomography and optical Doppler imaging15,16 provide blood vasculature anatomy imaging with high spatial resolution and sensitive measurements of flow speed, but lack high sensitivity for measuring sO2 because their imaging contrasts are based on optical scattering.

Recently, photoacoustic microscopy (PAM) has emerged as a powerful modality for biomedical imaging.1719 In PAM, tissue is irradiated by a short-pulsed laser beam. Some of the light is absorbed and partially converted to heat, which subsequently induces acoustic waves [termed photoacoustic (PA) waves] via thermoelastic expansion. Because hemoglobin has strong absorption in the visible spectral region, PAM has high sensitivity in blood vasculature anatomy imaging20 and flow imaging.21,22 In addition, because oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (Hb) have different absorption spectra, PAM can also accurately measure sO2. Thus, all the aforementioned microcirculatory parameters, including blood flow rate, blood volume, and blood oxygen saturation (sO2), can be measured by PAM. So far, functional PAM has been successfully demonstrated in both animals2325 and humans.26

The diagnosis of CRPS is based on clinical manifestations and there are limited laboratory tests or image studies to verify the diagnosis. With its high spatial resolution and label-free nature, PAM is potentially an ideal tool for monitoring and diagnosing CRPS by imaging peripheral blood perfusion. In this work, we performed a series of experiments to show the feasibility of this new imaging tool.

2. Methods

2.1. Subjects

In this prospective observational study, we screened patients with a possible diagnosis of CRPS-1, who were referred to the Pain Management Center of Washington University in St. Louis between January 2011 and December 2011. Nine adult patients (28 to 69 years old, six female, three male) with CRPS-1 were recruited. Patients with pain in only one upper extremity were selected to participate in the study. One patient withdrew from the study. Patients were considered to be candidates for the study if they were diagnosed with CRPS-1 by using the proposed new diagnostic criteria of the International Association for the Study of Pain.27 All patients signed consents to be involved in the study. All human research procedures were carried out in conformity with the protocol approved by the Institutional Review Board at Washington University in St. Louis.

For all the patients, symptoms and signs of CRPS were present for less than one year. Average pain level was 5 or higher on a numerical rating score scale of 0 to 10 (with 0 being no pain and 10 being the worst imaginable pain). Exclusion criteria were pregnancy, coagulopathy, fever, general infection or local infection at the block puncture site, substance abuse, peripheral neuropathy, or any other diseases that may account for signs and symptoms mimicking CRPS.

2.2. Procedures

Benefits and risks of stellate ganglion block (SGB) were explained to the patients in detail. A written consent was obtained for the procedure. ASA standard monitors were applied during the procedure and postprocedure in the recovery room. The skin temperature of the hands was measured before and 10 min after the procedure. SGB on the cervical sympathetic chain was performed at the C7 vertebral level using the standard anterior paratracheal approach under fluoroscopic guidance. The patient was placed in the supine position with the head slightly hyperextended. The needle entry point was fluroscopically identified by anterior-posterior view at the junction of the C7 vertebral body and transverse process on the side of the diseased limb. Sterile techniques were used throughout the entire procedure. After sterilization and preparation, 1 to 3 ml of 1% lidocaine was used for skin infiltration at the needle entry point. Then a 10-mm, 25-gauge nerve block needle was inserted and advanced to the junction of the transverse process and the corresponding C7 vertebral body. Bony contact was made. The appropriate needle positioning was confirmed by anterior-posterior and lateral views. Once the needle was confirmed in the correct position fluoroscopically, aspiration was made for negative blood and other body fluids. Then a small amount (0.5 to 1 ml) of contrast dye was injected to visualize and prevent potential intravascular injection. After an adequate craniocaudal contrast dye spread from C5 to T1 was obtained, an injection of 10 ml of 0.25% bupivacaine with 1:200,000 epinephrine was given in 2-ml increments, with interval negative aspiration. The patient was observed in the recovery area for 15 min after the procedure. Skin temperature in the block side increased 1.1±0.1°C 10 min after SGB. Meanwhile, the pain level reduced by 2.5±0.6 on discharge.

The experimental paradigm consisted of two imaging sessions with an SGB between the sessions. For each patient, the back of their hand and the cuticle of the same hand were imaged before SGB (baseline) and then after SGB. Two sites [Fig. 1(B)] were chosen to image: superficial microvasculature at the cuticle and deeper and larger vessels at the back of the hand.

Fig. 1.

Fig. 1

(A) Schematic of the optical-resolution (OR-PAM) and acoustic-resolution photoacoustic microscopy (AR-PAM) systems. AL, acoustic lens; CL, conical lens; DAQ, data acquisition system; M, mirror; UT, ultrasound transducer. (B) Photograph of the hand, showing the scanned regions: (a) region scanned by AR-PAM and (b) region scanned by OR-PAM.

2.3. Photoacoustic Microscopy

According to its light illumination mechanism, PAM can be classified into two categories: acoustic-resolution (AR-) PAM and optical-resolution (OR-) PAM. In AR-PAM, the light is weakly focused and the lateral resolution is determined by the acoustic focusing of the ultrasonic transducer. In OR-PAM, the light is tightly focused, thus the lateral resolution is determined by the optical focusing provided by the objective. The axial resolution of both AR- and OR-PAM is determined by the bandwidth of the transducer used in the system. Usually optical focusing is much tighter than acoustic focusing, therefore, OR-PAM has a better lateral resolution than AR-PAM. However, since acoustic scattering is much weaker than optical scattering in soft tissue, AR-PAM can focus deeper than OR-PAM. To monitor hemodynamic changes with both high spatial resolution and deep penetration, both AR- and OR-PAM systems were used in this research. The schematics are shown in Fig. 1(A). In the AR-PAM system, a donut-shaped illumination is formed when light passes through the conical lens. A 20-MHz ultrasonic transducer collects the PA signals. In the OR-PAM system, light illumination and acoustic collection are achieved by an ultrasound-optical beam combiner. A 50-MHz ultrasonic transducer detects the PA signals. Each laser pulse generates a one-dimensional depth-resolved image (A-line) in both the AR- and OR-PAM systems. By two-dimensional (2-D) raster-scanning of the entire area, a three-dimensional (3-D) image can be acquired. For more accurate sO2 calculation in both AR- and OR-PAM systems, a photodiode compensates for the local fluence fluctuation. A detailed system description can be found in our previous papers.2830 The lateral resolutions of the AR- and OR-PAM systems are 80 and 3  μm, respectively. To measure sO2, light at two wavelengths, 570 and 578 nm, was used in both AR- and OR-PAM. The PA signal from both wavelengths can be described as

P(λ1)=k×[εHb(λ1)CHb+εHbO2(λ1)CHbO2], (1)
P(λ2)=k×[εHb(λ2)CHb+εHbO2(λ2)CHbO2], (2)

where P denotes PA signal amplitude, λ1 and λ2 denote the first and second wavelengths, k denotes a system-dependent constant, ε denotes the molar extinction coefficient, Hb denotes deoxygenated hemoglobin, HbO2 denotes the oxygenated hemoglobin, and C denotes the molar concentration. Based on Eqs. (1) and (2), we can solve for CHb and CHbO2. In the end, sO2 can be calculated as

sO2=CHbO2CHbO2+CHb. (3)

3. Results

Typical AR- and OR-PAM hand images of patients are shown in Figs. 2 and 3, respectively. For fair comparisons, the distance between the patient’s hand and the ultrasonic transducer was adjusted to be the same before and after SGB for imaging. In AR-PAM, a 6  mm by 6 mm field of view was scanned. Signals down to 1 mm deep were collected. Due to the high axial resolution of AR-PAM, we were able to differentiate signals from different depths. Maximum-amplitude-projection images along the depth direction, with ranges of 0.4 to 0.7 mm and 0.7 to 1.0 mm, are shown in Fig. 2. Two major differences can be easily seen: more blood vessels and stronger signals after the block. Because the local optical fluence fluctuation had been compensated for, the PA signal was mainly dependent on the absorption coefficient of the target. Thus, an increase in the PA signal indicates an increase in the local absorption coefficient, probably due to increased blood concentration or volume. Therefore, we suspect that there was increasing blood perfusion and blood vessel dilation after the block.

Fig. 2.

Fig. 2

Maximum amplitude projection (MAP) images of vasculature in the back of one patient’s hand by AR-PAM. MAP image in the depth range between 0.4 and 0.7 mm before block (a) and after block (b). MAP image in the depth range between 0.7 and 1 mm before block (c) and after block (d). NPA, normalized photoacoustic amplitude.

Fig. 3.

Fig. 3

OR-PAM vasculature image of the fingertip of one patient. MAP of scanned region before block (a) and after block (b). The dashed box represents the region used for statistical analysis. (c) Close-up image of the capillary loop indicated by the arrow in (b).

Typical blood vessels in the finger cuticle imaged by OR-PAM are shown in Fig. 3. As indicated in Figs. 3(b) and 3(c), OR-PAM successfully imaged a single capillary loop, which is the smallest vessel in human blood circulation.31 As shown in Fig. 3(b), a stronger signal was found after the block which is consistent with the results from AR-PAM.

Statistical analysis of all the patient data are shown in Fig. 4. Figure 4(a) shows the average increase in signal intensity at different depths after the block. On average, there was >50% signal increase in all depth ranges. In addition, the signal increased most within the 0.1- to 0.4-mm depth range, where the capillary bed is located. Similar results from OR-PAM can be found in Fig. 4(c). According to the dual-wavelength measurement by AR-PAM, the average sO2 increased 4%.

Fig. 4.

Fig. 4

(a) Normalized photoacoustic (PA) signal measured by AR-PAM before and after block in different depth ranges. (b) Average sO2 measured by AR-PAM before and after block. (c) Normalized PA signal measured by OR-PAM before and after block.

4. Discussion

CRPS-1 is a difficult clinical condition to diagnose and treat. Early diagnosis and management are necessary to prevent a long-standing or permanent disability. The diagnosis of CRPS-1 is primarily based on clinical observation and assessment of symptoms and signs, although a diagnostic algorithm has recently been proposed.32 A unique pathophysiological mechanism for CRPS-1 has not yet been established, therefore, sensitive and specific laboratory diagnostic parameters are lacking, resulting in difficulties in making valid diagnosis and distinguishing CRPS from other extremity pain entities. Several diagnostic procedures, such as bone scintigraphy, plain radiographs, quantitative sensory testing, skin temperature measurements, and fMRI are used to support the diagnosis of CRPS. However, they require pathognomonic markers. For example, the recommended three-phase bone scan demonstrated both cortical and cancellous osteopenia in CRPS patients and controls treated with casting.33 Meanwhile, there are no universally accepted tools to measure the effectiveness of treatment. It is known that CRPS is accompanied by impaired microcirculation of the affected tissue,3436 such as vasoconstriction and reduced regional blood flow37 and oxygenation,14 which then leads to skin temperature change,34,38 pain, and atrophic changes. Thus, a direct noninvasive measurement of microcirculation is of considerable interest for accurate and early diagnosis of CRPS. PAM is shown to be a powerful tool for studying the microcirculatory system at the site of CRPS. In the presented results, the blood perfusion increase after SGB was directly observed, which is consistent with the patients’ subjective sense of pain relief. Based on time-of-flight in the depth direction and raster 2-D scanning in the horizontal direction, PAM can reconstruct 3-D information of the blood vessel anatomy and the distributions of hemoglobin concentration and oxygen saturation, which may provide additional information for diagnosis and improvement after treatment. Our experiments show that a relatively obvious blood perfusion increase after SGB exists at the shallow depth where the capillary bed is located. Although the data are preliminary, they suggest a strong relation between the development of CRPS and microcirculatory changes.

PAM is able to measure the oxygen saturation in a single blood vessel29 or the average values in a desired area. Pain, autonomic changes, and functioning impairment in patients with CRPS may be related more to the actual tissue extraction of oxygen and nutrients in the affected area than to the supply of oxygen and nutrients from microcirculation. Some reports suggest that arterial oxygen saturation alone may not be helpful enough to diagnose CRPS,39,40 thus venous oxygen saturation is essential.40 Due to its absorption contrast mechanism, PAM with double wavelengths is sensitive to both oxyhemoglobin and deoxyhemoglobin, and is able to measure the oxygen saturation in both arteries and veins.

SGB with local anesthetics is used frequently in the management of CRPS-1 of the upper extremities, with variable degrees of success in pain relief and improvement of function.5 This inconsistency of outcome may be related to sympathetically maintained pain (SMP) and sympathetically independent pain (SIP).41 SMP may be differentiated from SIP by a sympatholytic challenge provided by an intravenous injection of the α-adrenergic blocker phentolamine or sympathetic blocks.42,43 Our preliminary data indicated only a subset of patients responded to SGB well, with significant pain relief and changes of PA signal and sO2, which supports the observation that “neuropathic pain is mediated or maintained by the sympathetic nervous system in only a subset of patients.”43

Despite the advantages listed above, the 2-D scanning of current PAM has a relatively long acquisition time, which leads to some motion artifacts in the image. Further improvement of imaging speed is possible by implementing mirror scanning.44 Limited by the strong attenuation of high-frequency acoustic signals, the AR-PAM system used in this work can image only as deep as 3 mm in biological tissue. To investigate the microcirculatory changes of deep tissue, such as muscles and bones in the area affected by CRPS, an AR-PAM system with a lower central frequency transducer (e.g., 5 MHz) can be used in the future, which would extend the imaging depth to 4 cm.25 Based on a small number of subjects, our data are promising but preliminary. Randomized, controlled, and double-blinded clinical trials are needed to verify the clinical application of PAM systems to CRPS evaluation and management.

5. Conclusion

In this paper, peripheral blood vessels in two sites in patients’ hands were imaged by PAM systems. From pre- to post-SGB block, there were a 50% increase in signal intensity of PAM and 4% increase in sO2, which agreed with the increased temperature and decreased pain level.6,7 The results showed that blood perfusion increased after SBG, which is consistent with prior reports. Unlike other imaging methods, PAM can provide noninvasive high spatial resolution images as well as functional sO2 measurement. In these preliminary results, PAM showed its potential in helping both monitoring and diagnosing CRPS.

Acknowledgments

This work was sponsored in part by National Institutes of Health grants DP1 EB016986 (NIH Director’s Pioneer Award), R01 CA186567 (NIH Director’s Transformative Research Award), and R01 CA159959. L.V. W. has a financial interest in Microphotoacoustics, Inc. and Endra, Inc., which, however, did not support this work; K.I. M. has a financial interest in Microphotoacoustics, Inc.

Biography

Biographies of the authors are not available.

References

  • 1.Bruehl S., “An update on the pathophysiology of complex regional pain syndrome,” Anesthesiology 113(3), 713–725 (2010). 10.1097/ALN.0b013e3181e3db38 [DOI] [PubMed] [Google Scholar]
  • 2.Lubenow T., Jaycox M., “Current trends in the diagnosis and treatment of complex regional pain syndrome,” ASA Refresh. Courses Anesthesiol. 40(1), 95–104 (2012). 10.1097/ASA.0b013e31826305ed [DOI] [Google Scholar]
  • 3.Schwartzman R. J., Alexander G. M., Grothusen J., “Pathophysiology of complex regional pain syndrome,” Expert Rev. Neurother. 6(5), 669–681 (2006). 10.1586/14737175.6.5.669 [DOI] [PubMed] [Google Scholar]
  • 4.Parkitny L., et al. , “Inflammation in complex regional pain syndrome A systematic review and meta-analysis,” Neurology 80(1), 106–117 (2013). 10.1212/WNL.0b013e31827b1aa1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.van Eijs F., et al. , “Predictors of pain relieving response to sympathetic blockade in complex regional pain syndrome type 1,” Anesthesiology 116(1), 113–121 (2012). 10.1097/ALN.0b013e31823da45f [DOI] [PubMed] [Google Scholar]
  • 6.Schurmann M., et al. , “Assessment of the peripheral microcirculation using computer-assisted venous congestion plethysmography in post-traumatic complex regional pain syndrome type I,” J. Vasc. Res. 38(5), 453–461 (2001). 10.1159/000051078 [DOI] [PubMed] [Google Scholar]
  • 7.Dirckx M., et al. , “Effect of immunomodulating medications in complex regional pain syndrome A systematic review,” Clin. J. Pain 28(4), 355–363 (2012). 10.1097/AJP.0b013e31822efe30 [DOI] [PubMed] [Google Scholar]
  • 8.Moisset X., Bouhassira D., “Brain imaging of neuropathic pain,” Neuroimage 37(S1), S80–S88 (2007). 10.1016/j.neuroimage.2007.03.054 [DOI] [PubMed] [Google Scholar]
  • 9.Owen D., et al. , “Quantification of pain-induced changes in cerebral blood flow by perfusion MRI,” Pain 136(1), 85–96 (2008). 10.1016/j.pain.2007.06.021 [DOI] [PubMed] [Google Scholar]
  • 10.Lebel A., et al. , “fMRI reveals distinct CNS processing during symptomatic and recovered complex regional pain syndrome in children,” Brain 131(7), 1854–1879 (2008). 10.1093/brain/awn123 [DOI] [PubMed] [Google Scholar]
  • 11.Detre J. A., et al. , “Perfusion imaging,” Magn. Reson. Med. 23(1), 37–45 (1992). 10.1002/(ISSN)1522-2594 [DOI] [PubMed] [Google Scholar]
  • 12.Coghill R. C., et al. , “Global cerebral blood flow decreases during pain,” J. Cereb. Blood Flow Metab. 18(2), 141–147 (1998). 10.1097/00004647-199802000-00003 [DOI] [PubMed] [Google Scholar]
  • 13.Okano T., et al. , “Use of near-infrared spectroscopy to evaluate stellate ganglion block,” Reg. Anesth Pain Med. 26(2), 186 (2001). 10.1053/rapm.2001.21827 [DOI] [PubMed] [Google Scholar]
  • 14.Koban M., et al. , “Tissue hypoxia in complex regional pain syndrome,” Pain 104(1–2), 149–157 (2003). 10.1016/S0304-3959(02)00484-0 [DOI] [PubMed] [Google Scholar]
  • 15.Zhao Y., et al. , “Phase-resolved optical coherence tomography and optical Doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity,” Opt. Lett. 25(2), 114–116 (2000). 10.1364/OL.25.000114 [DOI] [PubMed] [Google Scholar]
  • 16.Ackerman W. E., Munir M. A., Zhang J.-M., “Assessment of laser Doppler imaging for the diagnosis of complex regional pain syndrome I,” J. Neuropathic Pain Symptom Palliation 1(4), 13–20 (2005). 10.3109/J426v01n04_03 [DOI] [Google Scholar]
  • 17.Wang X., et al. , “Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain,” Nat. Biotechnol. 21(7), 803–806 (2003). 10.1038/nbt839 [DOI] [PubMed] [Google Scholar]
  • 18.Zhang H. F., et al. , “Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging,” Nat. Biotechnol. 24(7), 848–851 (2006). 10.1038/nbt1220 [DOI] [PubMed] [Google Scholar]
  • 19.Zhou Y., et al. , “Photoacoustic microscopy of bilirubin in tissue phantoms,” J. Biomed. Opt. 17(12), 126019 (2012). 10.1117/1.JBO.17.12.126019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhang C., et al. , “Slow-sound photoacoustic microscopy,” Appl. Phys. Lett. 102(16), 163702 (2013). 10.1063/1.4803444 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Liang J. Y., et al. , “Cross-correlation-based transverse flow measurements using optical resolution photoacoustic microscopy with a digital micromirror device,” J. Biomed. Opt. 18(9), 096004 (2013). 10.1117/1.JBO.18.9.096004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhou Y., et al. , “Calibration-free in vivo transverse blood flowmetry based on cross correlation of slow time profiles from photoacoustic microscopy,” Opt. Lett. 38(19), 3882–3885 (2013). 10.1364/OL.38.003882 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Liao L. D., et al. , “Transcranial imaging of functional cerebral hemodynamic changes in single blood vessels using in vivo photoacoustic microscopy,” J. Cereb. Blood Flow Metab. 32(6), 938–951 (2012). 10.1038/jcbfm.2012.42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Liang J. Y., et al. , “Random-access optical-resolution photoacoustic microscopy using a digital micromirror device,” Opt. Lett. 38(15), 2683–2686 (2013). 10.1364/OL.38.002683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wang L. H. V., Hu S., “Photoacoustic tomography: in vivo imaging from organelles to organs,” Science 335(6075), 1458–1462 (2012). 10.1126/science.1216210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Favazza C. P., Cornelius L. A., Wang L. V., “In vivo functional photoacoustic microscopy of cutaneous microvasculature in human skin,” J. Biomed. Opt. 16(2), 026004 (2011). 10.1117/1.3536522 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Harden R. N., et al. , “Validation of proposed diagnostic criteria (the ‘Budapest Criteria’) for complex regional pain syndrome,” Pain 150(2), 268–274 (2010). 10.1016/j.pain.2010.04.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Maslov K., Stoica G., Wang L. V., “In vivo dark-field reflection-mode photoacoustic microscopy,” Opt. Lett. 30(6), 625–627 (2005). 10.1364/OL.30.000625 [DOI] [PubMed] [Google Scholar]
  • 29.Hu S., Maslov K., Wang L. V., “Second-generation optical-resolution photoacoustic microscopy with improved sensitivity and speed,” Opt. Lett. 36(7), 1134–1136 (2011). 10.1364/OL.36.001134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zhou Y., Yao J. J., Wang L. H. V., “Optical clearing-aided photoacoustic microscopy with enhanced resolution and imaging depth,” Opt. Lett. 38(14), 2592–2595 (2013). 10.1364/OL.38.002592 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Braverman I. M., “The cutaneous microcirculation,” J. Investig. Dermatol. Symp. Proc. 5(1), 3–9 (2000). 10.1046/j.1087-0024.2000.00010.x [DOI] [PubMed] [Google Scholar]
  • 32.Perez R. S. G. M., et al. , “Diagnostic criteria for CRPS I: differences between patient profiles using three different diagnostic sets,” Eur. J. Pain 11(8), 895–902 (2007). 10.1016/j.ejpain.2007.02.006 [DOI] [PubMed] [Google Scholar]
  • 33.Bickerstaff D. R., Kanis J. A., “Algodystrophy: an under-recognized complication of minor trauma,” Br. J. Rheumatol. 33(3), 240–248 (1994). 10.1093/rheumatology/33.3.240 [DOI] [PubMed] [Google Scholar]
  • 34.Wasner G., et al. , “Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value,” Brain 124(3), 587–599 (2001). 10.1093/brain/124.3.587 [DOI] [PubMed] [Google Scholar]
  • 35.Baron R., et al. , “Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study,” Lancet 359(9318), 1655–1660 (2002). 10.1016/S0140-6736(02)08589-6 [DOI] [PubMed] [Google Scholar]
  • 36.Albrecht P. J., et al. , “Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome,” Pain 120(3), 244–266 (2006). 10.1016/j.pain.2005.10.035 [DOI] [PubMed] [Google Scholar]
  • 37.Kurvers H., et al. , “Reflex sympathetic dystrophy: evolution of microcirculatory disturbances in time,” Pain 60(3), 333–340 (1995). 10.1016/0304-3959(94)00133-Y [DOI] [PubMed] [Google Scholar]
  • 38.Birklein F., et al. , “Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS),” Pain 87(2), 227 (2000). 10.1016/S0304-3959(00)00286-4 [DOI] [PubMed] [Google Scholar]
  • 39.Tan E. C., de Keijzer M. H., Goris R. J. A., “Capillary blood gas analysis in complex regional pain syndrome: a pilot study,” Ann. Clin. Biochem. 40(5), 569–571 (2003). 10.1258/000456303322326524 [DOI] [PubMed] [Google Scholar]
  • 40.Tan E. C., et al. , “Impaired oxygen utilization in skeletal muscle of CRPS I patients,” J. Surg. Res. 173(1), 145–152 (2012). 10.1016/j.jss.2010.08.043 [DOI] [PubMed] [Google Scholar]
  • 41.Melzack R., et al. , “Trigeminal neuralgia and atypical facial pain: use of the McGill pain questionnaire for discrimination and diagnosis,” Pain 27(3), 297–302 (1986). 10.1016/0304-3959(86)90157-0 [DOI] [PubMed] [Google Scholar]
  • 42.Raja S. N., et al. , “Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain,” Anesthesiology 74(4), 691–698 (1991). 10.1097/00000542-199104000-00012 [DOI] [PubMed] [Google Scholar]
  • 43.Raja S. N., Treede R.-D., “Testing the link between sympathetic efferent and sensory afferent fibers in neuropathic pain,” Anesthesiology 117(1), 173–177 (2012). 10.1097/ALN.0b013e31825adb2b [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Yao J., et al. , “Wide-field fast-scanning photoacoustic microscopy based on a water-immersible MEMS scanning mirror,” J. Biomed. Opt. 17(8), 080505 (2012). 10.1117/1.JBO.17.8.080505 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Biomedical Optics are provided here courtesy of Society of Photo-Optical Instrumentation Engineers

RESOURCES